mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |